KAJO Neurotechnologies developes human based in vitro neurodegeneration models for drug discovery.
Our advanced stem cell derived models can lead to better results in target identification and validation leading to increased hit-rate for new drug candidates for neurodegenerative disorders with better translational power than animal based models.
KAJO Neurotechnologies is an academic Research to Business project affiliated with the University of Helsinki and funded by Business Finland.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Helsinki, Fi
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- HQ
- Helsinki
Kajo Neurotechnologies Project Questions
Kajo Neurotechnologies Project's LinkedIn profile is https://fi.linkedin.com/company/kajo-neurotechnologies
Kajo Neurotechnologies Project has
3 employees.
View email and phone details for 3
employees at Kajo Neurotechnologies Project.
Kajo Neurotechnologies Project's industry is
Research Services
Kajo Neurotechnologies Project's top competitors are
Multivisiondx,
The Science Basement Ry,
Polku Therapeutics,
Significo Research Ltd,
Blueprint Genetics,
City-Lab Oy,
Art Sofware Oy,
Elva Bio,
Mitoguarder,
Neuroeye.
Kajo Neurotechnologies Project's categories are Research Services
Kajo Neurotechnologies Project's founding year is 2024
